Prognostic significance of ground-glass areas within tumours in non-small-cell lung cancer

Author:

Sakurai Hiroyuki1,Goto Yasushi2ORCID,Yoh Kiyotaka3,Takamochi Kazuya4ORCID,Shukuya Takehiro5,Hishida Tomoyuki6ORCID,Tsuboi Masahiro7,Yoshida Koichi8,Ohde Yasuhisa9ORCID,Okumura Sakae10,Taguri Masataka11,Kunitoh Hideo12

Affiliation:

1. Division of Respiratory Surgery, Nihon University School of Medicine , Tokyo, Japan

2. Department of Thoracic Oncology, National Cancer Center Hospital , Tokyo, Japan

3. Department of Thoracic Oncology, National Cancer Center Hospital East , Kashiwa, Japan

4. Department of General Thoracic Surgery, Graduate School of Medicine, Juntendo University , Tokyo, Japan

5. Department of Respiratory Medicine, Graduate School of Medicine, Juntendo University , Tokyo, Japan

6. Division of Thoracic Surgery, Department of Surgery, Keio University School of Medicine , Tokyo, Japan

7. Division of Thoracic Surgery, National Cancer Center Hospital East , Kashiwa, Japan

8. Department of Thoracic Surgery, Tokyo Medical University School of Medicine , Tokyo, Japan

9. Division of Thoracic Surgery, Shizuoka Cancer Center , Shizuoka, Japan

10. Department of Thoracic Surgical Oncology, The Cancer Institute Hospital of JFCR , Tokyo, Japan

11. Department of Data Science, Tokyo Medical University School of Medicine , Tokyo, Japan

12. Department of Medical Oncology, Japanese Red Cross Medical Center , Tokyo, Japan

Abstract

Abstract OBJECTIVES To validate or refute the hypothesis that non-small-cell lung cancers (NSCLC) with ground-glass areas (GGA+) within the tumour on high-resolution computed tomography are associated with a more favourable prognosis than those without GGA (GGA−). METHODS We analysed data from a multicentre observational cohort study in Japan including 5005 patients with completely resected pathological stage I NSCLC, who were excluded from the Japan Clinical Oncology Group (JCOG) 0707 trial on oral adjuvant treatment during the enrolment period. The patients’ medical and pathological records were assessed retrospectively by physicians and re-staged according to the 8th tumour, node, metastasis edition. RESULTS Of the 5005 patients, 2388 (48%) were ineligible for the JCOG0707 trial and 2617 (52%) were eligible but were not enrolled. A total of 958 patients (19.1%) died. Patients with GGA+ NSCLC and pathological invasion ≤3 cm showed significantly better overall survival than others. In patients with tumours with an invasive portion ≤4 cm, GGA+ was associated with better survival. The prognoses of patients with GGA+ T2a and GGA− T1c tumours were similar (5-year overall survival: 84.6% vs 83.1%, respectively). The survival with T2b or more tumours appeared unaffected by GGA, and GGA was not prognostic in these larger tumours. CONCLUSIONS Patients with GGA+ NSCLC on high-resolution computed tomography and ≤4 cm invasion size may have a better prognosis than patients with solid GGA− tumours of the same T-stage. However, the presence or absence of radiological GGA has little impact on the prognosis of patients with NSCLC with greater (>4 cm) pathological invasion.

Funder

Taiho Pharmaceutical

The Comprehensive Support Project for Oncology Research

Public Health Research Foundation in Japan

Publisher

Oxford University Press (OUP)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3